5Hirsch AT, Haskal ZJ, Herizer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease(lower extremity; renal mesenterie and abdom final aortic)[J]. Circulation, 2006 113(11):463-654. 被引量：1
6[1]Criqui MH,Fronek A,Barrett-Connor E,et al.The prevalence of peripheral arterial disease in a defined population[J].Circulation,1985,71 (3):510-515 被引量：1
7[2]Newman AB,Sutton-Tyrrell K,Vogt MT,et al.Morbidity and mortality in hypertensive adults with alow ankle/arm blood pressure index[J].J am Med Assoc,1993,27(4):487-489 被引量：1
8[3]Klinkert P,Schepers A,Burger DH,et al.Vein versus poly-tetrafluoroethylene in above-knee femoropopliteal by pass grafting:five-year results of a randomized controlled trial[J].J Vasc Surg,2003,37(1):149-155 被引量：1
9[4]WU ZJ,Qian XX,Cai DH,et al.Long-termoral administeration of L-arginine enhance endothelium-depedent vasorelaxation and inhibits neointimal thickening after endethelial denudationin rats[J].Clin Med J,1996,109(8):592 被引量：1
10[5]Isner JM,Feldman LJ.Gene therapy for arterial disease[J].Lancet,1994,344(8938):1653 被引量：1
